Highlights
1 patentProfile claimed by owner
About
Surgical Ophthalmic Laser Devices and Accessories
IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye. The company also offers a line of patented eye drops to treat ocular surface diseases. IOPtima is a Kanghong Pharmaceutical company.
Identity
| Name | IOPtima |
|---|---|
| Slug | ioptima |
| Type / kind | startup |
| Crunchbase ID | ioptima |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6o3t0LDA |
Status
| Status | acquired |
|---|---|
| Status reason | Acquired by Chengdu Kanghong Pharmaceutical Group on Sep, 2018 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | Leshem St 10, Caesarea, Israel |
Web & social
| Website | https://www.ioptima.com |
|---|---|
| https://www.linkedin.com/company/5022298 | |
| Twitter / X | https://twitter.com/IOPtima |
| YouTube | https://www.youtube.com/user/IOPtimaVideos |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business models
B2B
Tags
medical-deviceseye-diseasesminimally-invasivesurgerylasersglaucomaophthalmologyhospitalspharma-companiesclinicshealthcare-providersmedical-technologiesoptronics
Funding
| Total raised | $7.2M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}